Table of Contents
FORM 6-K
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant toRule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
Commission FileNumber: 001-38757
For the month of January 2019
TAKEDA PHARMACEUTICAL COMPANY LIMITED
(Translation of registrant’s name into English)
1-1, Nihonbashi-Honcho2-Chome
Chuo-ku,Tokyo 103-8668
Japan
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under coverForm 20-F orForm 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting theForm 6-K in paper as permitted byRegulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting theForm 6-K in paper as permitted byRegulation S-T Rule 101(b)(7): ☐
Table of Contents
Information furnished on this form:
Exhibit | ||
1. | Notice Regarding the Determination of Subscription Requirements to Issue New Takeda Shares |
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TAKEDA PHARMACEUTICAL COMPANY LIMITED | ||||||
Date: January 7, 2019 | By: | /s/ Mitsuhiro Okada | ||||
Mitsuhiro Okada | ||||||
Head of Global Treasury & Finance Management |
Table of Contents
![]() | Better Health, Brighter Future |
Notice Regarding the Determination of Subscription Requirements to Issue New Takeda Shares
Osaka, Japan, January 7, 2019 - Under the authority delegated by the resolution at the extraordinary shareholders meeting held on December 5, 2018, Takeda Pharmaceutical Company Limited(TSE: 4502/NYSE: TAK) (“Takeda”) has on January 5, 2019 determined the subscription requirements to issue new Takeda shares as a part of the consideration relating to the proposed acquisition of Shire plc (“Shire”) by Takeda as follows.
Type of shares for subscription | Ordinary shares of Takeda | |
Number of shares for subscription | 770,303,013 shares | |
Amount per share to be paid in | JPY 7,601 | |
Property other than monies to be contributed | Ordinary shares of Shire plc will be contributed. | |
Description of contributed property | 918,120,398 ordinary shares of Shire plc | |
Value of contributed property | JPY 5,855,073,208,821.12 | |
Amounts of capital and capital reserves to be increased* | The amount of stated capital to be increased shall be half of the maximum amount of increase in stated capital, as calculated in accordance with the provisions of Article 14, paragraph 1 of the Rules of Corporate Accounting, with any fraction less than one yen resulting from the calculation being rounded up to the nearest one yen. The amount of capital reserves to be increased shall be the amount obtained by subtracting the said amount of stated capital to be increased from the maximum amount of increase of stated capital. | |
Date of contribution | January 8, 2019 |
* | Actual amounts will be reported accordingly. |
###